Evidence map›Paper›PMID 28750085›Full record

ArticlePloS one2017

Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression.

Yaochen Zhang, Don-Kyu Kim, Yan Lu, Yoon Seok Jung, Ji-Min Lee, Young-Hoon Kim, Yong Soo Lee, Jina Kim, Bedair Dewidar, Won-Il Jeong and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Regulation of fibrinogen synthesis.Thrombosis research · 2024
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Yaochen ZhangNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Don-Kyu KimNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Yan LuShanghai Institute of Endocrinology and Metabolism, Shanghai Key Laboratory for Endocrine Tumors, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yoon Seok JungNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Ji-Min LeeNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Young-Hoon KimKorea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Yong Soo LeeNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Jina KimNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Bedair DewidarDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Won-Il JeongGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
In-Kyu LeeDepartment of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
Sung Jin ChoNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Steven DooleyDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Chul-Ho LeeKorea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Xiaoying LiShanghai Institute of Endocrinology and Metabolism, Shanghai Key Laboratory for Endocrine Tumors, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hueng-Sik ChoiNational Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.ORCID http://orcid.org/0000-0002-3163-1572
Chonnam National University · KRHeidelberg University · DEKorea Research Institute of Bioscience and Biotechnology · KRKyungpook National University Hospital · KRShanghai Jiao Tong University · CNDaegu-Gyeongbuk Medical Innovation Foundation · KRKorea Advanced Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrinogen, 1 of 13 coagulation factors responsible for normal blood clotting, is synthesized by hepatocytes. Detailed roles of the orphan nuclear receptors regulating fibrinogen gene expression have not yet been fully elucidated. Here, we identified estrogen-related receptor gamma (ERRγ) as a novel transcriptional regulator of human fibrinogen gene expression. Overexpression of ERRγ specially increased fibrinogen expression in human hepatoma cell line. Cannabinoid receptor types 1(CB1R) agonist arachidonyl-2'-chloroethylamide (ACEA) up-regulated transcription of fibrinogen via induction of ERRγ, whereas knockdown of ERRγ attenuated fibrinogen expression. Deletion analyses of the fibrinogen γ (FGG) gene promoter and ChIP assays revealed binding sites of ERRγ on human fibrinogen γ gene promoter. Moreover, overexpression of ERRγ was sufficient to increase fibrinogen gene expression, whereas treatment with GSK5182, a selective inverse agonist of ERRγ led to its attenuation in cell culture. Finally, fibrinogen and ERRγ gene expression were elevated in liver tissue of obese patients suggesting a conservation of this mechanism. Overall, this study elucidates a molecular mechanism linking CB1R signaling, ERRγ expression and fibrinogen gene transcription. GSK5182 may have therapeutic potential to treat hyperfibrinogenemia.

Indexed as

Gene Expression RegulationAdultAgedAnimalsFibrinogenGene Knockdown TechniquesHep G2 CellsHumansLiverMiceMiddle AgedNon-alcoholic Fatty Liver DiseaseObesityPromoter Regions, GeneticReceptor, Cannabinoid, CB1Receptors, EstrogenESRRG protein, humanFibrinogenReceptor, Cannabinoid, CB1Receptors, Estrogen

Identifiers

PMID28750085
PMCPMC5531639
OpenAlexW2740513985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.